Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

NCT05677594 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05677594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2021
Completion date
June 30, 2028
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical neurofibroma, malignant peripheral nerve sheath tumor (mpnst) of soft tissue (diagnosis), neurofibromatosis 1